|
US6923964B1
(en)
|
1997-12-02 |
2005-08-02 |
Neuralab Limited |
Active immunization of AScr for prion disorders
|
|
US7588766B1
(en)
|
2000-05-26 |
2009-09-15 |
Elan Pharma International Limited |
Treatment of amyloidogenic disease
|
|
US6743427B1
(en)
|
1997-12-02 |
2004-06-01 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US7790856B2
(en)
|
1998-04-07 |
2010-09-07 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6913745B1
(en)
|
1997-12-02 |
2005-07-05 |
Neuralab Limited |
Passive immunization of Alzheimer's disease
|
|
US7179892B2
(en)
*
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7964192B1
(en)
|
1997-12-02 |
2011-06-21 |
Janssen Alzheimer Immunotherapy |
Prevention and treatment of amyloidgenic disease
|
|
US6750324B1
(en)
|
1997-12-02 |
2004-06-15 |
Neuralab Limited |
Humanized and chimeric N-terminal amyloid beta-antibodies
|
|
US6761888B1
(en)
|
2000-05-26 |
2004-07-13 |
Neuralab Limited |
Passive immunization treatment of Alzheimer's disease
|
|
TWI239847B
(en)
*
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
US20080050367A1
(en)
*
|
1998-04-07 |
2008-02-28 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US6787523B1
(en)
*
|
1997-12-02 |
2004-09-07 |
Neuralab Limited |
Prevention and treatment of amyloidogenic disease
|
|
US20030147882A1
(en)
*
|
1998-05-21 |
2003-08-07 |
Alan Solomon |
Methods for amyloid removal using anti-amyloid antibodies
|
|
US7148324B1
(en)
*
|
1998-12-14 |
2006-12-12 |
Dendreon Corporation |
Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
|
|
US6787637B1
(en)
|
1999-05-28 |
2004-09-07 |
Neuralab Limited |
N-Terminal amyloid-β antibodies
|
|
UA81216C2
(en)
|
1999-06-01 |
2007-12-25 |
|
Prevention and treatment of amyloid disease
|
|
ES2248283T3
(es)
*
|
2000-02-21 |
2006-03-16 |
Pharmexa A/S |
Nuevo procedimiento para reducir los niveles de amiloide.
|
|
CZ20022748A3
(cs)
*
|
2000-02-21 |
2004-03-17 |
Pharmexa A/S |
Nová metoda regulace obsahu amyloidu
|
|
WO2002003911A2
(en)
|
2000-07-07 |
2002-01-17 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
US7700751B2
(en)
|
2000-12-06 |
2010-04-20 |
Janssen Alzheimer Immunotherapy |
Humanized antibodies that recognize β-amyloid peptide
|
|
TWI255272B
(en)
*
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
US7097837B2
(en)
*
|
2001-02-19 |
2006-08-29 |
Pharmexa A/S |
Synthetic vaccine agents
|
|
US20040191264A1
(en)
*
|
2001-02-19 |
2004-09-30 |
Nielsen Klaus Gregorius |
Synthetic vaccine agents
|
|
US6815175B2
(en)
|
2001-03-16 |
2004-11-09 |
Cornell Research Foundation, Inc. |
Anti-amyloid peptide antibody based diagnosis and treatment of a neurological disease or disorder
|
|
WO2002074931A2
(en)
*
|
2001-03-20 |
2002-09-26 |
University Of Chicago |
Inhibitors and disassemblers of fibrillogenesis
|
|
MY144532A
(en)
*
|
2001-08-20 |
2011-09-30 |
Lundbeck & Co As H |
Novel method for down-regulation of amyloid
|
|
EP1572894B1
(en)
*
|
2001-11-21 |
2016-04-13 |
New York University |
Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
|
|
MY139983A
(en)
*
|
2002-03-12 |
2009-11-30 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2003256578A1
(en)
*
|
2002-07-17 |
2004-02-02 |
Intellect Neurosciences, Inc. |
Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
|
|
EP1560850A2
(en)
*
|
2002-11-14 |
2005-08-10 |
Adherex Technologies, Inc. |
Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
|
|
WO2004056318A2
(en)
|
2002-12-19 |
2004-07-08 |
New York University |
Method for treating amyloid disease
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
GB0310270D0
(en)
*
|
2003-05-03 |
2003-06-11 |
Univ Edinburgh |
Biomolecular devices
|
|
TWI374893B
(en)
|
2003-05-30 |
2012-10-21 |
Janssen Alzheimer Immunotherap |
Humanized antibodies that recognize beta amyloid peptide
|
|
AR047062A1
(es)
|
2003-12-17 |
2006-01-04 |
Wyeth Corp |
Conjugados portadores de peptidos inmunogenicos a beta y metodos para producirlos
|
|
SE0401601D0
(sv)
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
BRPI0516279A
(pt)
*
|
2004-10-06 |
2008-09-02 |
Hiroshi Mori |
proteìna amilóide variante humana, peptìdeo, gene humano, mrna. cdna sintetizado, anticorpo, método de diagnóstico de doenças amilóides, método para classificação de um componente do agente terapêutico para as doenças amilóides, e fármaco anti-doença amilóide
|
|
EP1838349A1
(en)
*
|
2004-12-15 |
2007-10-03 |
Neuralab, Ltd. |
Amyloid beta antibodies for use in improving cognition
|
|
TW200635607A
(en)
*
|
2004-12-15 |
2006-10-16 |
Elan Pharm Inc |
Humanized Aβ antibodies for use in improving cognition
|
|
WO2006066049A2
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
CA2607004C
(en)
|
2005-05-05 |
2016-01-26 |
Sensient Flavors Inc. |
Production of beta-glucans and mannans
|
|
CN117903302A
(zh)
|
2005-11-30 |
2024-04-19 |
Abbvie 公司 |
抗-Aβ球聚体抗体，其相关产品，生产所述抗体的方法，所述抗体的应用以及使用方法
|
|
PT1976877E
(pt)
*
|
2005-11-30 |
2014-04-29 |
Abbvie Inc |
Anticorpos monoclonais contra proteína beta-amilóide e suas utilizações
|
|
RU2429244C2
(ru)
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
|
US8784810B2
(en)
*
|
2006-04-18 |
2014-07-22 |
Janssen Alzheimer Immunotherapy |
Treatment of amyloidogenic diseases
|
|
US20090123488A1
(en)
*
|
2006-08-14 |
2009-05-14 |
Thymon, Llc |
Compositions and methods for the treatment and prophylaxis of Alzheimer's disease
|
|
WO2008021295A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Thymon, L.L.C. |
Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1
|
|
WO2008070284A2
(en)
|
2006-10-16 |
2008-06-12 |
Johnnie B. Byrd, Sr. Alzheimer's Center And Research Institute |
Amyloid beta peptides and methods of uses thereof
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
TW200902063A
(en)
|
2007-02-15 |
2009-01-16 |
Univ Kumamoto |
Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient
|
|
EP2123298A4
(en)
*
|
2007-02-15 |
2011-09-28 |
Univ Fukuoka |
AGENT FOR SUPPRESSING REJECTION IN AN ORGAN TRANSPLANT COMPRISING ANTI-HMGB-1 ANTIBODY
|
|
JP5241518B2
(ja)
*
|
2007-02-15 |
2013-07-17 |
国立大学法人九州大学 |
抗ｈｍｇｂ−１抗体を含む間質性肺疾患治療剤
|
|
US20100311767A1
(en)
*
|
2007-02-27 |
2010-12-09 |
Abbott Gmbh & Co. Kg |
Method for the treatment of amyloidoses
|
|
WO2008106657A2
(en)
*
|
2007-03-01 |
2008-09-04 |
Intezyne Technologies, Inc. |
Encapsulated amyloid-beta peptides
|
|
US8003097B2
(en)
*
|
2007-04-18 |
2011-08-23 |
Janssen Alzheimer Immunotherapy |
Treatment of cerebral amyloid angiopathy
|
|
CN101970000A
(zh)
*
|
2007-04-18 |
2011-02-09 |
杨森阿尔茨海默氏症免疫治疗公司 |
脑淀粉样血管病的预防和治疗
|
|
DK2182983T3
(da)
|
2007-07-27 |
2014-07-14 |
Janssen Alzheimer Immunotherap |
Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
|
|
JO3076B1
(ar)
*
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
KR101581733B1
(ko)
|
2007-11-16 |
2015-12-31 |
더 락커펠러 유니버시티 |
원섬유 형태의 베타아밀로이드 단백질에 대해 특이적인 항체
|
|
AU2009266552B2
(en)
*
|
2008-07-01 |
2014-01-23 |
De Staat Der Nederlanden, Vert. Door De Minister Van Vws |
Vaccine against amyloid folding intermediate
|
|
US9067981B1
(en)
|
2008-10-30 |
2015-06-30 |
Janssen Sciences Ireland Uc |
Hybrid amyloid-beta antibodies
|
|
TWI508976B
(zh)
*
|
2009-04-21 |
2015-11-21 |
Univ Rockefeller |
對β－類澱粉蛋白之基原纖維形式具專一性之抗體
|
|
US8409584B2
(en)
|
2009-05-05 |
2013-04-02 |
New York University |
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
|
|
US8748386B2
(en)
|
2009-06-10 |
2014-06-10 |
New York University |
Immunological targeting of pathological Tau proteins
|
|
CN101920008B
(zh)
*
|
2009-06-15 |
2013-07-31 |
浙江仙琚制药股份有限公司 |
包含Aβ40多肽和铝佐剂的制剂以及纯化Aβ40多肽的方法
|
|
CN104744591B
(zh)
|
2010-04-15 |
2022-09-27 |
Abbvie德国有限责任两合公司 |
β淀粉样蛋白结合蛋白
|
|
EP3533803B1
(en)
|
2010-08-14 |
2021-10-27 |
AbbVie Inc. |
Anti-amyloid-beta antibodies
|
|
US9926353B2
(en)
|
2011-07-19 |
2018-03-27 |
New York University |
Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
|
|
US8906382B2
(en)
|
2011-07-19 |
2014-12-09 |
New York University |
Method for treating amyloid disease
|
|
RS61717B1
(sr)
|
2014-07-10 |
2021-05-31 |
Bioarctic Ab |
Poboljšana antitela koja vezuju a-beta protofibril
|
|
WO2018038973A1
(en)
*
|
2016-08-20 |
2018-03-01 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Neuroprotective beta amyloid core peptides and peptidomimetic derivatives
|
|
CN119136838A
(zh)
|
2022-02-28 |
2024-12-13 |
特瑞德姆生物科技有限责任两合公司 |
由至少一种β-葡聚糖或甘露聚糖组成或包含至少一种β-葡聚糖或甘露聚糖的偶联物
|
|
MX2024010450A
(es)
|
2022-02-28 |
2024-09-18 |
Tridem Bioscience Gmbh & Co Kg |
Conjugado que consiste de o que comprende al menos un beta-glucano o un manano.
|